Literature DB >> 6266839

GABA and baclofen potentiate the K+-evoked release of methionine-enkephalin from rat striatal slices.

J Sawynok, F S Labella.   

Abstract

GABA potentiates the potassium-evoked release of methionine-enkephalin (ME) from slices of rat corpus striatum. This potentiation is observed only when a submaximal concentration (30 mM) of K+ is used to evoke release. The effect of GABA is dose-dependent between 100 and 100 micrometers. The basal release of ME is not altered by these concentrations of GABA. Before, but not muscimol, mimics the effect of GABA on the evoked release of ME. This effect is not stereoselective as both the (+)- and (-)-isomers of baclofen enhance ME release. Picrotoxin (100 micrometers) blocks the enhancement of ME release produced by both GABA and baclofen. Bicuculline methiodide (100 micrometers) does not block the effect of GABA. The effect of GABA on ME release may be mediated by an atypical GABA receptor which is activated by baclofen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266839     DOI: 10.1016/0014-2999(81)90204-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Modulation of non-adrenergic, non-cholinergic neural bronchoconstriction in guinea-pig airways via GABAB-receptors.

Authors:  M G Belvisi; M Ichinose; P J Barnes
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

Review 2.  GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates.

Authors:  Y Smith; A Charara; J E Hanson; M Paquet; A I Levey
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

3.  Naloxone does not alter the effect of gamma aminobutyric acid derivative, baclofen, on GH release in man.

Authors:  P Chiodera; R Volpi; V Coiro; L Barilli; G Rossi; E Roti
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

4.  Bicuculline insensitive effects of baclofen.

Authors:  L K Rägo; A M Zarkovsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.